Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quest Diagnostics

189.51
+2.691.44%
Post-market: 189.510.00000.00%17:02 EDT
Volume:983.92K
Turnover:186.23M
Market Cap:21.19B
PE:22.71
High:190.08
Open:187.61
Low:187.05
Close:186.82
52wk High:191.49
52wk Low:146.91
Shares:111.82M
Float Shares:111.23M
Volume Ratio:1.12
T/O Rate:0.88%
Dividend:3.10
Dividend Rate:1.64%
EPS(TTM):8.35
EPS(LYR):7.80
ROE:14.26%
ROA:6.34%
PB:2.93
PE(LYR):24.29

Loading ...

More Fentanyl Shows Up in Random Workplace Tests -- WSJ

Dow Jones
·
Sep 02

Quest Diagnostics Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Aug 30

BRIEF-Corewell Health And Quest Diagnostics To Enter Into Joint Venture Providing Enhanced Laboratory Services In Michigan

Reuters
·
Aug 26

Corewell Health and Quest Diagnostics to Enter Into Joint Venture Providing Enhanced Laboratory Services in Michigan

THOMSON REUTERS
·
Aug 26

Quest Diagnostics Inc: Additional Terms Were Not Disclosed

THOMSON REUTERS
·
Aug 26

Patrick Plewman, SVP for Diagnostic Services, Reports Disposal of Quest Diagnostics Common Shares

Reuters
·
Aug 26

Quest Diagnostics Cut to Neutral From Outperform by Baird

Dow Jones
·
Aug 25

FDA Grants Breakthrough Device Designation to Quest Diagnostics' Haystack MRD Circulating Tumor DNA Test for Stage II Colorectal Cancer

Reuters
·
Aug 25

FDA Grants Breakthrough Device Designation for Haystack Mrd Circulating Tumor DNA Test From Quest Diagnostics

THOMSON REUTERS
·
Aug 25

Baird Downgrades Quest Diagnostics to Neutral From Outperform, Price Target is $194

MT Newswires Live
·
Aug 25

Quest Diagnostics Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Aug 23

Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 20

Patrick Plewman, SVP for Diagnostic Services, Reports Disposal of Quest Diagnostics Common Shares

Reuters
·
Aug 20

Quest Diagnostics CEO to Discuss Strategy at Baird 2025 Global Healthcare Conference

Reuters
·
Aug 16

Quest Diagnostics Declares Quarterly Cash Dividend of $0.80 Per Share

Reuters
·
Aug 14

Cardio Diagnostics Holdings Inc. Announces Date for Virtual Annual Stockholders Meeting

Reuters
·
Aug 13

Quest Diagnostics Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Aug 09

Patrick Plewman, SVP for Diagnostic Services, Reports Disposal of Common Shares of Quest Diagnostics Incorporated

Reuters
·
Aug 09

Quest Diagnostics and Mass General Brigham Launch Clinical Trials to Evaluate Haystack MRD ctDNA for Post-Surgical Cancer Treatment

Reuters
·
Aug 07

Mass General Brigham Launches Two Clinical Trials to Study Haystack Mrd Ctdna as Guide for Post-Surgical Treatment for Two Cancer Types

THOMSON REUTERS
·
Aug 07